In this thesis, the prognostic value of clinical risk factors, the use of noninvasive testing for risk stratification, and pharmacologic risk reduction strategies are described for the perioperative and long-term management of patients undergoing major vascular surgery.

, ,
Bristol-Myers Squibb, Cardialysis, Merck Nederland, Merck Sharp & Dohme, Novartis, Pfizer, Poldermans, Prof. Dr. D. (promotor), Sanofi Synthelebo
D. Poldermans (Don)
Erasmus University Rotterdam
hdl.handle.net/1765/7268
Erasmus MC: University Medical Center Rotterdam

Kertai, M. (2004, May 12). Travelling beyond the current frontiers: Perioperative and long-term cardiac risk assessment and management of patients undergoing major vascular surgery. Retrieved from http://hdl.handle.net/1765/7268